Profound Medical completes US$17.4 million bought deal prospectus offering

On November 14, 2016, Profound Medical Corp. completed a bought deal short form prospectus offering of 15,820,000 common shares (the “Common Shares”) at an issue price of $1.10 per Common Share for aggregate gross proceeds of $17,402,000 (the “Offering”). The Offering was conducted by a syndicate of underwriters led by GMP Securities L.P. (“GMP”) and including Echelon Wealth Partners Inc. and Mackie Research Capital Corp. Fasken Martineau advised GMP with a team that included John Sabetti, Rubin Rapuch, Jessica Catton Rinaldi and David Steinhauer (Securities/Corporate), with assistance from Timothy Squire (Regulatory), Mitchell Thaw (Tax) and Christelle Gedeon (IP).